Amgen Inc. (AMGN) — Business segments and KPIs
Revenue by business segment and geography for Amgen Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Other Products | 7.26B | 20.6% |
| Prolia | 4.41B | 12.5% |
| Repatha | 3.02B | 8.5% |
| Otezla | 2.27B | 6.4% |
| ENBREL | 2.23B | 6.3% |
| EVENITY | 2.10B | 5.9% |
| XGEVA | 2.08B | 5.9% |
| TEPEZZA | 1.90B | 5.4% |
| Product and Service, Other | 1.60B | 4.5% |
| BLINCYTO | 1.56B | 4.4% |
| Nplate | 1.52B | 4.3% |
| TEZSPIRE | 1.48B | 4.2% |
| Aranesp | 1.39B | 3.9% |
| KRYSTEXXA | 1.34B | 3.8% |
| Vectibix | 1.18B | 3.3% |
| Revenue by region | ||
| UNITED STATES | 26.42B | 71.9% |
| Non-US | 10.33B | 28.1% |